Expiration Compliance — Enforce expiration date and beyond-date rules in dispensing and inventory decisions

The concept of drug expiration dates is a relatively modern regulatory innovation. For much of pharmaceutical history, medications were compounded in small batches by individual pharmacists, and the idea of a standardized shelf life was foreign to practice. Patients and practitioners relied on organoleptic assessment — color, odor, taste, and texture — to determine whether a preparation remained suitable for use. This subjective approach led to significant variability in drug quality, and cases of patient harm from degraded medications prompted legislative action. The evolution of expiration dating requirements mirrors the broader professionalization and regulation of pharmacy practice in the United States.

The central question that drives expiration compliance in modern pharmacy practice is straightforward yet critical: How can pharmacists ensure that every medication dispensed to a patient retains its identity, strength, quality, and purity through its intended period of use? Answering this question requires understanding the interplay between federal regulations, state pharmacy laws, USP standards, and the professional judgment of the dispensing pharmacist.

Understanding expiration compliance begins with a precise vocabulary. Pharmacy law and practice distinguish between several closely related but legally distinct concepts, and confusing them is a common source of error on the MPJE. The expiration date assigned by a manufacturer reflects stability data obtained under controlled conditions for the original, sealed container. The beyond-use date (BUD) is the date after which a compounded preparation or a repackaged drug product should not be used, and it is assigned by the pharmacist based on professional judgment, USP guidelines, and available stability data.

The flowchart above captures the essential logic underlying every dispensing decision related to drug product dating. When a pharmacist receives a drug product, the first verification step is confirming that the manufacturer's expiration date is present and has not passed. Products lacking expiration dates — with the narrow exception of certain homeopathic products and grandfathered OTC drugs — must be quarantined and either returned to the wholesaler or destroyed through proper channels. When the product carries a valid expiration date and is dispensed directly in its original container, the pharmacist must ensure that the days' supply prescribed does not exceed the remaining time before expiration. This is a frequently tested concept on the MPJE: dispensing a 90-day supply of a medication that expires in 60 days violates federal and state pharmacy law, even if the product is currently within its labeled shelf life.

Expiration compliance operates at the intersection of federal statute, federal regulation, USP standards, and state pharmacy practice acts. Understanding which authority governs which aspect of dating is essential for MPJE preparation. Federal law, primarily through the FDCA and implementing regulations in Title 21 of the Code of Federal Regulations, establishes the baseline requirements. However, state boards of pharmacy often impose stricter standards, and the pharmacist must always comply with the most stringent applicable rule — a principle sometimes called the "stricter law prevails" doctrine.

Federal Requirements: 21 CFR §211.137

This regulation mandates that all drug products bear an expiration date determined by appropriate stability testing, reflecting the date beyond which the product cannot be expected to retain its labeled potency. The expiration date must appear on the immediate container label and, if applicable, on the outer packaging. When an expiration date is expressed as a month and year (e.g., 05/2026), the product is deemed to expire on the last day of the stated month — in this case, May 31, 2026. This convention is frequently tested on board examinations.

USP Beyond-Use Date Standards

Expiration compliance extends well beyond the moment of dispensing — it encompasses the entire lifecycle of a drug product within the pharmacy from receipt through storage, dispensing, and ultimately disposal. Effective inventory management practices are not merely best practices; they are legally required components of pharmacy operations in most states. State boards of pharmacy typically require documented evidence of routine expiration date monitoring programs, and failure to maintain such programs can constitute grounds for disciplinary action against the pharmacy license.

FEFO — First Expiring, First Out

The FEFO (First Expiring, First Out) principle is the gold standard for pharmacy stock rotation. Unlike the more general FIFO (First In, First Out) method used in general retail, FEFO prioritizes dispensing products with the nearest expiration date first, regardless of when they were received. This practice minimizes waste and reduces the risk of expired products remaining on shelves. When new stock arrives, it should be placed behind existing stock so that older products are naturally selected first. Many pharmacy management systems incorporate automated FEFO alerts, flagging products that will expire within 90 days so they can be prioritized for dispensing or returned to the wholesaler for credit before they become unsaleable.

• ✓ Monthly audits — most state boards require or recommend monthly checks of all shelf stock for approaching or passed expiration dates.
• ✓ 90-day return window — many wholesalers accept returns only within 90 days before or after expiration, making proactive monitoring financially important.
• ✓ Segregation of expired stock — expired products must be physically separated from active inventory and clearly labeled to prevent accidental dispensing.
• ✓ Documentation — records of expired product removal, returns, and destruction must be maintained for state board inspection, typically for a minimum of two years.

Let's work through a realistic scenario that integrates multiple expiration compliance concepts. This type of multi-step analysis is representative of what you will encounter on the MPJE.

Expiration compliance does not exist in isolation — it connects to several advanced regulatory and clinical domains that pharmacy students and practitioners must understand. The concepts discussed in this lesson serve as a foundation for more complex areas including drug recall procedures, Drug Supply Chain Security Act (DSCSA) traceability requirements, and the management of Risk Evaluation and Mitigation Strategies (REMS) programs that may impose additional dispensing restrictions.

The MPJE may also test your understanding of how expiration compliance intersects with emergency dispensing situations. During declared public health emergencies, the FDA may issue guidance permitting the temporary extension of expiration dates for specific products if stability data supports continued use. However, absent such emergency authorization, the pharmacist has no authority to independently extend a manufacturer's expiration date — doing so constitutes a violation of federal law and the state pharmacy practice act. This is a critical distinction that separates lawful professional judgment from unauthorized action.